OR51F2
gene geneOn this page
Summary
OR51F2 (olfactory receptor family 51 subfamily F member 2, HGNC:15197) is a protein-coding gene on chromosome 11p15.4, encoding Olfactory receptor 51F2 (Q8NH61). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 119694 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- MANE Select transcript:
NM_001004753
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15197 |
| Approved symbol | OR51F2 |
| Name | olfactory receptor family 51 subfamily F member 2 |
| Location | 11p15.4 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000176925 |
| Ensembl biotype | protein_coding |
| Entrez | 119694 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000322110, ENST00000641672
RefSeq mRNA: 1 — MANE Select: NM_001004753
NM_001004753
CCDS: CCDS31361
Canonical transcript exons
ENST00000322110 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003920805 | 4821321 | 4822456 |
Expression profiles
Bgee: expression breadth tissue_specific, 1 present calls, max score 51.40.
Top tissues by expression
130 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 51.40 | silver quality |
| lower esophagus mucosa | UBERON:0035834 | 39.06 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 35.88 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| monocyte | CL:0000576 | 29.21 | gold quality |
| liver | UBERON:0002107 | 29.14 | gold quality |
| leukocyte | CL:0000738 | 29.06 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| blood | UBERON:0000178 | 26.11 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
| muscle of leg | UBERON:0001383 | 25.59 | gold quality |
| right lobe of liver | UBERON:0001114 | 25.20 | gold quality |
| calcaneal tendon | UBERON:0003701 | 24.94 | gold quality |
| kidney | UBERON:0002113 | 24.78 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.47 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or51f2 | ENSMUSG00000073965 |
| rattus_norvegicus | Or51f2 | ENSRNOG00000015424 |
Paralogs (51): OR51E2 (ENSG00000167332), OR51B5 (ENSG00000167355), OR51I1 (ENSG00000167359), OR51Q1 (ENSG00000167360), OR52A5 (ENSG00000171944), OR52W1 (ENSG00000175485), OR51B6 (ENSG00000176239), OR51V1 (ENSG00000176742), OR52E2 (ENSG00000176787), OR51L1 (ENSG00000176798), OR51G2 (ENSG00000176893), OR51A7 (ENSG00000176895), OR51T1 (ENSG00000176900), OR51S1 (ENSG00000176922), OR51E1 (ENSG00000180785), OR56B4 (ENSG00000180919), OR52E4 (ENSG00000180974), OR52N2 (ENSG00000180988), OR52N1 (ENSG00000181001), OR52N5 (ENSG00000181009), OR56B2 (ENSG00000181017), OR56B1 (ENSG00000181023), OR52N4 (ENSG00000181074), OR52P1 (ENSG00000181109), OR52D1 (ENSG00000181609), OR52H1 (ENSG00000181616), OR52K2 (ENSG00000181963), OR52A1 (ENSG00000182070), OR51B4 (ENSG00000183251), OR52E8 (ENSG00000183269), OR52L1 (ENSG00000183313), OR51M1 (ENSG00000184698), OR52B6 (ENSG00000187747), OR51I2 (ENSG00000187918), OR52K1 (ENSG00000196778), OR51D1 (ENSG00000197428), OR51C1 (ENSG00000197674), OR52M1 (ENSG00000197790), OR52E6 (ENSG00000205409), OR52J3 (ENSG00000205495)
Protein
Protein identifiers
Olfactory receptor 51F2 — Q8NH61 (reviewed: Q8NH61)
Alternative names: Olfactory receptor OR11-23
All UniProt accessions (2): A0A2C9F2M5, Q8NH61
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_001004753* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
| IPR050402 | OR51/52/56-like | Family |
Pfam: PF13853
UniProt features (18 total): topological domain 8, transmembrane region 7, chain 1, glycosylation site 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NH61-F1 | 86.19 | 0.60 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 111–203
Glycosylation sites (1): 17
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 23 (showing top):
GOBP_CELLULAR_RESPONSE_TO_LIPID, GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, GOBP_RESPONSE_TO_LIPID, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, IGLV5_37_TARGET_GENES, REACTOME_OLFACTORY_SIGNALING_PATHWAY
GO Biological Process (6): cellular response to lipid (GO:0071396), system process (GO:0003008), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608), detection of chemical stimulus involved in sensory perception of smell (GO:0050911)
GO Molecular Function (3): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984), signaling receptor activity (GO:0038023)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| response to lipid | 1 |
| cellular response to chemical stimulus | 1 |
| multicellular organismal process | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| molecular transducer activity | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
162 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR51F2 | OLFM2 | O95897 | 348 |
| OR51F2 | TRIM68 | Q6AZZ1 | 305 |
| OR51F2 | IP6K3 | Q96PC2 | 301 |
| OR51F2 | TLDC2 | A0PJX2 | 270 |
| OR51F2 | FREM3 | P0C091 | 269 |
| OR51F2 | ZRANB2 | O95218 | 267 |
| OR51F2 | HBG1 | P02096 | 264 |
| OR51F2 | SPATA18 | Q8TC71 | 259 |
| OR51F2 | KIF23 | Q02241 | 248 |
| OR51F2 | ASPM | Q8IZT6 | 247 |
| OR51F2 | COXFA4L2 | Q9NRX3 | 245 |
| OR51F2 | OR4A16 | Q8NH70 | 239 |
| OR51F2 | TRIM34 | Q9BYJ4 | 226 |
| OR51F2 | PRDM5 | Q9NQX1 | 220 |
| OR51F2 | A0A0J9YYA3 | A0A0J9YYA3 | 212 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| OR51F2 | PDIA6 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (1): OR51F2 (Proximity Label-MS)
ESM2 similar proteins: A0A3B3IT45, A6NGY5, O88628, P0C646, Q6IFG1, Q8NGF0, Q8NGF1, Q8NGF3, Q8NGH6, Q8NGH7, Q8NGH9, Q8NGI0, Q8NGI2, Q8NGJ2, Q8NGJ3, Q8NGJ4, Q8NGJ5, Q8NGJ6, Q8NGJ7, Q8NGJ9, Q8NGK1, Q8NGK2, Q8NGK3, Q8NGK4, Q8NGK5, Q8NGK6, Q8NH53, Q8NH55, Q8NH56, Q8NH57, Q8NH59, Q8NH60, Q8NH61, Q8NH63, Q8NH64, Q8TCB6, Q8VBV9, Q96RD2, Q96RD3, Q9H255
Diamond homologs: A0A3B3IT45, A4D2G3, A6NF89, A6NGY5, A6NL08, A6NL26, A6NMU1, A6NND4, O88628, P0C629, P0C646, P0C7N1, P0C7T3, P23266, P23273, P23274, P30954, Q13606, Q60888, Q62007, Q6IF63, Q6IFG1, Q6W049, Q8NGA6, Q8NGF0, Q8NGF1, Q8NGF3, Q8NGG8, Q8NGH5, Q8NGH6, Q8NGH7, Q8NGH8, Q8NGH9, Q8NGI0, Q8NGI1, Q8NGI2, Q8NGI3, Q8NGI7, Q8NGJ2, Q8NGJ3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
341 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:4821499:G:GG | donor_gain | 0.9300 |
| 11:4821498:A:AG | donor_gain | 0.7900 |
| 11:4821598:GCC:G | donor_gain | 0.6700 |
| 11:4821594:A:AG | donor_gain | 0.6600 |
| 11:4822048:A:AG | acceptor_gain | 0.6600 |
| 11:4822049:G:GG | acceptor_gain | 0.6600 |
| 11:4822086:T:TA | acceptor_gain | 0.6500 |
| 11:4821483:GCC:G | donor_gain | 0.6300 |
| 11:4821600:C:CG | donor_gain | 0.6300 |
| 11:4822107:GCATT:G | acceptor_gain | 0.6300 |
| 11:4821600:C:G | donor_gain | 0.6200 |
| 11:4822043:A:AG | acceptor_gain | 0.6200 |
| 11:4821607:C:CG | donor_gain | 0.6100 |
| 11:4822048:AG:A | acceptor_gain | 0.6100 |
| 11:4822049:GG:G | acceptor_gain | 0.6100 |
| 11:4821411:A:AG | acceptor_gain | 0.6000 |
| 11:4821412:G:GG | acceptor_gain | 0.6000 |
| 11:4821820:A:G | donor_gain | 0.6000 |
| 11:4822046:ACAG:A | acceptor_gain | 0.6000 |
| 11:4821946:C:A | donor_gain | 0.5900 |
| 11:4822049:GGGT:G | acceptor_gain | 0.5900 |
| 11:4821594:A:G | donor_gain | 0.5800 |
| 11:4821861:GGA:G | donor_gain | 0.5800 |
| 11:4821919:G:GT | donor_gain | 0.5800 |
| 11:4822048:AGG:A | acceptor_gain | 0.5800 |
| 11:4822049:GGG:G | acceptor_gain | 0.5800 |
| 11:4821863:A:G | donor_gain | 0.5700 |
| 11:4821871:GTTGA:G | donor_gain | 0.5700 |
| 11:4821872:TTGAT:T | donor_gain | 0.5700 |
| 11:4822107:GC:G | acceptor_gain | 0.5700 |
AlphaMissense
2173 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:4821929:T:C | F182L | 0.923 |
| 11:4821931:C:A | F182L | 0.923 |
| 11:4821931:C:G | F182L | 0.923 |
| 11:4822196:A:C | S271R | 0.886 |
| 11:4822198:T:A | S271R | 0.886 |
| 11:4822198:T:G | S271R | 0.886 |
| 11:4822178:T:C | F265L | 0.871 |
| 11:4822180:C:A | F265L | 0.871 |
| 11:4822180:C:G | F265L | 0.871 |
| 11:4821461:T:C | F26L | 0.852 |
| 11:4821463:C:A | F26L | 0.852 |
| 11:4821463:C:G | F26L | 0.852 |
| 11:4822265:T:C | F294L | 0.838 |
| 11:4822267:T:A | F294L | 0.838 |
| 11:4822267:T:G | F294L | 0.838 |
| 11:4821964:C:G | C193W | 0.837 |
| 11:4821731:T:C | F116L | 0.830 |
| 11:4821733:C:A | F116L | 0.830 |
| 11:4821733:C:G | F116L | 0.830 |
| 11:4821978:T:C | L198P | 0.827 |
| 11:4821794:T:C | F137L | 0.826 |
| 11:4821796:T:A | F137L | 0.826 |
| 11:4821796:T:G | F137L | 0.826 |
| 11:4821962:T:A | C193S | 0.818 |
| 11:4821963:G:C | C193S | 0.818 |
| 11:4821641:A:C | S86R | 0.799 |
| 11:4821643:C:A | S86R | 0.799 |
| 11:4821643:C:G | S86R | 0.799 |
| 11:4821792:G:C | R136P | 0.799 |
| 11:4821962:T:C | C193R | 0.797 |
dbSNP variants (sampled 300 via entrez): RS1000381622 (11:4820289 A>G), RS1000579753 (11:4820654 C>A), RS1001900909 (11:4819953 C>T), RS1002506790 (11:4820190 T>C), RS1003517169 (11:4819878 C>A), RS1005189792 (11:4822434 T>C), RS1006204353 (11:4821188 A>C), RS1006350678 (11:4819768 T>TG), RS1007132321 (11:4821748 T>C), RS1008170329 (11:4820949 T>G), RS1009136102 (11:4819402 G>A,C), RS1009225568 (11:4820221 C>T), RS1012553181 (11:4820223 T>C), RS1013048742 (11:4822481 C>A,T), RS1013278165 (11:4822668 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010725_20 | Malaria | 4.000000e-69 |
| GCST010725_33 | Malaria | 2.000000e-67 |
| GCST010725_51 | Malaria | 1.000000e-55 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| CGP 52608 | affects binding, increases reaction | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Plant Extracts | decreases expression, affects cotreatment | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.